Mingchen Health Co.,Ltd.
SZSE:002919.SZ
26.78 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,637.568 | 945.405 | 744.149 | 680.571 | 517.463 | 546.277 | 641.639 | 596.121 | 587.565 | 559.213 | 426.488 |
| Cost of Revenue
| 650.657 | 449.069 | 369.212 | 391.671 | 318.142 | 339.252 | 399.669 | 375.999 | 371.625 | 347.373 | 237.784 |
| Gross Profit
| 986.91 | 496.336 | 374.936 | 288.901 | 199.322 | 207.025 | 241.971 | 220.121 | 215.94 | 211.84 | 188.703 |
| Gross Profit Ratio
| 0.603 | 0.525 | 0.504 | 0.424 | 0.385 | 0.379 | 0.377 | 0.369 | 0.368 | 0.379 | 0.442 |
| Reseach & Development Expenses
| 111.268 | 110.264 | 98.508 | 46.27 | 15.531 | 14.978 | 17.7 | 15.917 | 17.094 | 14.679 | 0 |
| General & Administrative Expenses
| 24.705 | 25.538 | 19.294 | 14.418 | 11.867 | 11.97 | 9.805 | 8.329 | 9.468 | 7.675 | 43.222 |
| Selling & Marketing Expenses
| 664.665 | 321.04 | 83.332 | 74.745 | 110.898 | 117.767 | 125.981 | 109.985 | 100.352 | 121.126 | 117.419 |
| SG&A
| 689.37 | 346.578 | 102.626 | 89.163 | 122.766 | 129.736 | 135.786 | 118.314 | 109.82 | 128.8 | 160.641 |
| Other Expenses
| -1.304 | 50.898 | 52.538 | 40.489 | 36.261 | 2.324 | 0.195 | 1.542 | 0.254 | 4.252 | 0.474 |
| Operating Expenses
| 884.912 | 507.74 | 253.671 | 175.922 | 174.558 | 177.051 | 188.11 | 169.626 | 162.013 | 173.776 | 163.9 |
| Operating Income
| 57.938 | 16.83 | 126.747 | 105.151 | 26.958 | 31.786 | 55.709 | 54.137 | 51.242 | 32.209 | 23.417 |
| Operating Income Ratio
| 0.035 | 0.018 | 0.17 | 0.155 | 0.052 | 0.058 | 0.087 | 0.091 | 0.087 | 0.058 | 0.055 |
| Total Other Income Expenses Net
| -44.833 | -1.58 | 0.76 | -0.389 | -0.761 | 4.137 | 2.044 | 5.094 | -2.93 | -1.621 | -0.918 |
| Income Before Tax
| 56.634 | 15.25 | 127.507 | 104.762 | 26.197 | 34.111 | 55.904 | 55.589 | 50.997 | 36.443 | 23.885 |
| Income Before Tax Ratio
| 0.035 | 0.016 | 0.171 | 0.154 | 0.051 | 0.062 | 0.087 | 0.093 | 0.087 | 0.065 | 0.056 |
| Income Tax Expense
| -13.731 | -10.08 | -5.987 | 2.522 | 3.121 | 4.45 | 7.395 | 8.18 | 7.489 | 4.657 | 2.956 |
| Net Income
| 70.365 | 25.389 | 133.494 | 102.24 | 23.077 | 29.661 | 48.509 | 47.409 | 43.509 | 31.786 | 20.93 |
| Net Income Ratio
| 0.043 | 0.027 | 0.179 | 0.15 | 0.045 | 0.054 | 0.076 | 0.08 | 0.074 | 0.057 | 0.049 |
| EPS
| 0.32 | 0.12 | 0.6 | 0.46 | 0.1 | 0.13 | 0.29 | 0.29 | 0.28 | 0.2 | 0.24 |
| EPS Diluted
| 0.32 | 0.12 | 0.6 | 0.46 | 0.1 | 0.13 | 0.29 | 0.29 | 0.28 | 0.2 | 0.24 |
| EBITDA
| 278.668 | 67.14 | 170.229 | 134.819 | 43.309 | 46.024 | 64.806 | 57.95 | 63.606 | 51.251 | 33.183 |
| EBITDA Ratio
| 0.17 | 0.071 | 0.229 | 0.198 | 0.084 | 0.084 | 0.101 | 0.097 | 0.108 | 0.092 | 0.078 |